index - Thérapie génique pour la DMD & physiopathologie du muscle squelettique Accéder directement au contenu

Dernières publications

Chiffres clés

48 Publications avec texte intégral

Open Access

67 %

Mots clés

Dystrophie musculaire de Becker DMD Metabolism Dystrophine Cell Biology Delivery Muscle Biology Antisense oligonucleotides Calcium Channels Génomique LncARN Humans Dynamin 2 Liver Diseases Becker BMD muscular dystrophy LncRNA Mitochondrial fission Dystrophie Musculaire de Duchenne DMD Clinical trials Duchenne DMD dystrophy Muscles/physiopathology Inbred C57BL Dystrophin Duchenne muscular dystrophy DMD CaVβs Cardiomyopathy Multiresolution modeling Drp1 Molecular Sequence Data Centronuclear myopathy Homeostasis MES Hepatocellular carcinoma Gene modifiers Muscle development L-Type BMD Immunoglobulin Fc Fragments/pharmacology Activin Receptors Inhibitors Animals Knockout Exon skipping Cultured LKB1 Inbred mdx Myogenesis Dystrophy Autophagy CaV subunits Becker muscular dystrophy Hear Muscle Strength Multi exon skipping Genomic Mdx mouse Skeletal muscle Cell Line Morphogenesis DMO Epigenetics Animal/physiopathology DHPR α1S Male Dystrophin-EGFP Energy Metabolism/drug effects Cachexia MiARN Cardiomyopathie Base Sequence Cells Multi resolution modeling Cell homeostasis CTNNB1 Allele‐specific silencing therapy NAD+ CD38 Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Invivo Muscular dystrophy Muscle Muscular Dystrophy Long QT Becker muscular dystrophy BMD NNOS Dystrophin central domain Dystrophie Musculaire de Becker BMD Human Umbilical Vein Endothelial Cells Muscular Atrophy Myotendinous junction Calcium Gene expression Duchenne muscular dystrophy Modificateurs de gènes Long noncoding RNA Molecular docking Gene Expression Regulation/drug effects Mice Ex-vivo